- Home
- DXCM
DXCM
DexCom Inc.
as 09-12-2025 9:37am EST
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 31.7B | IPO Year: | 2005 |
| Target Price: | $99.89 | AVG Volume (30 days): | 4.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 19 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.43 | EPS Growth: | -11.42 |
| 52 Week Low/High: | $57.52 - $93.25 | Next Earning Date: | 10-23-2025 |
| Revenue: | $4,300,800,000 | Revenue Growth: | 9.30% |
| Revenue Growth (this year): | 17.03% | Revenue Growth (next year): | 15.59% |
Stock Insider Trading Activity of DexCom Inc. (DXCM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Malady Kyle | DXCM | Director | Sep 5 '25 | Sell | $80.86 | 667 | $53,933.62 | 22,667 | |
| Stern Sadie | DXCM | EVP, Chief HR Officer | Sep 4 '25 | Sell | $80.00 | 1,466 | $117,280.00 | 105,223 | |
| Sylvain Jereme M | DXCM | EVP, Chief Financal Officer | Sep 2 '25 | Sell | $74.17 | 4,824 | $357,796.08 | 118,657 | |
| Brown Michael Jon | DXCM | EVP, Chief Legal Officer | Aug 15 '25 | Sell | $80.29 | 500 | $40,145.00 | 94,102 | |
| FOLETTA MARK G | DXCM | N/A | Aug 15 '25 | Sell | $81.28 | 2,750 | $222,902.82 | 51,316 | |
| Brown Michael Jon | DXCM | EVP, Chief Legal Officer | Jun 16 '25 | Sell | $82.80 | 500 | $41,400.00 | 94,102 | |
| FOLETTA MARK G | DXCM | Director | Jun 16 '25 | Sell | $83.13 | 2,750 | $228,604.75 | 51,316 |
Latest DexCom Inc. News
DXCM Breaking Stock News: Dive into DXCM Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
Oscar Health, Penumbra, DexCom, Merit Medical Systems, and HCA Healthcare Shares Are Falling, What You Need To Know
Business Wire Videos
2 days ago
Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day
Argus Research
3 days ago
DXCM: Lowering target price to $45.00
Barchart
3 days ago
How Is DexCom's Performance Compared to Other Medical Device Companies?
MT Newswires
4 days ago
Sector Update: Health Care Stocks Softer Late Afternoon
MT Newswires
4 days ago
Sector Update: Health Care Stocks Slipping Monday Afternoon
MT Newswires
4 days ago
Sector Update: Health Care
StockStory
4 days ago
Why DexCom (DXCM) Shares Are Sliding Today
Compare DXCM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DXCM DexCom Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.